Learn More
Breast cancer epidemiology and survival recently saw major changes resulting from improved screening and treatment modalities. This paper aims to provide an overview of changes in recent years in(More)
This study examined which patient- and physician-related factors influence guideline violations in adjuvant chemotherapy. In a prospective multi-center cohort study, patients with primary breast(More)
It is well accepted that innovation in oncology is transported through randomized clinical trials (CT), furthermore there is some evidence that patients profit from participation in CT. However,(More)
  • 1